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Antibacterial properties and 
regenerative potential of Sr2+ 
and ce3+ doped fluorapatites; 
a potential solution for peri-
implantitis
A. D. Anastasiou1,7, M. nerantzaki2,3, E. Gounari4, M. S. Duggal5, P. V. Giannoudis6, A. Jha1 & 
D. Bikiaris3
Scaffolds and implants in orthopaedics and regenerative dentistry usually fail because of bacterial 
infections. A promising solution would be the development of biomaterials with both significant 
regenerative potential and enhanced antibacterial activity. Working towards this direction, fluorapatite 
was synthesised and doped with Sr2+ and ce3+ ions in order to tailor its properties. After experiments 
with four common bacteria (i.e. E. Coli, S. Aureus, B. Subtilis, B. Cereus), it was found that the undoped 
and the ce3+ doped fluorapatites present better antibacterial response than the Sr2+ doped material. 
The synthesised minerals were incorporated into chitosan scaffolds and tested with Dental Pulp Stem 
Cells (DPSCs) to check their regenerative potential. As was expected, the scaffolds containing Sr2+-
doped fluorapatite, presented high osteoconductivity leading to the differentiation of the DPSCs into 
osteoblasts. Similar results were obtained for the Ce3+-doped material, since both the concentration 
of osteocalcin and the RUNX2 gene expression were considerably higher than that for the un-
doped mineral. Overall, it was shown that doping with Ce3+ retains the good antibacterial profile of 
fluorapatite and enhances its regenerative potential, which makes it a promising option for dealing with 
conditions where healing of hard tissues is compromised by bacterial contamination.
Infections associated with bacterial colonisation around implants and scaffolds is a significant clinical problem 
both in orthopaedics and regenerative dentistry. Epidemiological studies suggest that between 12% and 43% 
of the dental implants will develop at some point symptoms of peri-implantitis when in orthopaedics, 2–5% of 
all the implant related procedures will be further complicated by bacterial infections1. Although so far, the use 
of antibiotics is a common practice for preventing or treating these conditions, the potential risk of antibiotic 
resistance is a growing concern and the effectiveness of their long-term use is disputable. In order to meet the crit-
ical clinical need against antibacterial resistance and overcome the long-term health implications of the current 
treatment strategies, there is an increased interest for the development of novel biomaterials with both intrinsic 
antimicrobial properties and the potential to trigger bone regeneration.
Calcium phosphates (CaPs), due to their structural and chemical similarity with the natural mineral of bone 
and dental hard tissues, are some of the most commonly used biomaterials for the fabrication of medical devices 
and implants2–4. Amongst them, hydroxyapatite [HAP: Ca10(PO4)6(OH)2], brushite (DCPD: CaHPO4·2H2O) and 
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tricalcium phosphate [TCP: Ca3(PO4)2] are the most well documented, with also many reports concerning the 
use of fluorapatite (FAP: Ca5(PO4)3F) particularly in dentistry. Apart from the enhanced biocompatibility and 
bone regenerative potential, another advantage of such phosphate materials is the capability of tailoring their 
properties via anionic or/and cationic substitutions. Following that concept, Ca2+ ions can be partially replaced by 
metal ions like Ag+, Zn2+ and Sr2+ for imparting antibacterial properties to the biomaterials. However, the incor-
poration of these ions does not affect only the interaction of the materials with the bacteria but in many cases, 
it was found to have beneficial effects on the metabolism of tissue regeneration. Sr2+ and Ce3+ doped calcium 
phosphates are two characteristic examples of this behaviour.
Strontium can be found in dental enamel in concentrations less than 1000 ppb5. Sr2+ ions play a significant 
role during new bone formation by stimulating osteoblasts and simultaneous inhibition of bone resorption by 
suspending the function of osteoclasts. For this reason strontium modified calcium phosphate cements, have 
been explored for treating osteoporosis6, fixation of bone defects7, implant coatings and other biomedical appli-
cations8–10. Moreover, there are some reports to support that Sr containing minerals present antibacterial activity. 
Guida, et al.11, investigated the effect of Sr2+ in glass ionomer cements and observed bacterial inhibition with the 
release of Sr2+ ions. Strontium containing hydroxyapatite was also found to have particularly improved antibac-
terial effects on Escherichia coli, Staphylococcus aureus and Lactobacillus, showing potential to anti-caries applica-
tions in dentistry12,13. However, based on other reports the antibacterial potential of Sr2+ ions, is disputable. For 
example, Kumar et al.14, demonstrated that Sr2+-doped calcium phosphate nanoparticles show a weak antibacte-
rial effect on Staphylococcus aureus and no effect on Escherichia coli even at high concentrations (i.e. 300 μg/μl) in 
contrast with Ag+ doped nanoparticles which proved to have clear antibacterial impact.
Cerium is a rare earth element which also has been used in biomaterials to stimulate antibacterial activity. 
In a recent work, Gopi et al.15, investigated the synergistic actions of Sr2+ and Ce3+ in hydroxyapatite nano-
particles. The results indicated that Ce3+ doped particles show extremely strong effect on Escherichia coli and 
Staphylococcus aureus even at low concentrations. Furthermore, in other works cerium was investigated to have 
significant pharmacological potential due to the antioxidant properties of Ce3+ and Ce4+ ions16 and although the 
exact role of cerium (Ce-ions) to the metabolism is still unclear, there is evidence that link it with angiogenesis 
through regulation of the intracellular oxygen17.
In the present work Sr2+ and Ce3+ doped fluorapatites (FAP) were synthesised in order to evaluate the anti-
bacterial properties and regenerative potential, targeting to provide improved biomaterials for dental related 
applications. FAP was chosen over other calcium phosphates, based on the beneficial effect of fluoride on enamel. 
Absorption of the fluoride ions from enamel crystals is considered to offer protection from demineralisation18 
and at the same time it appears to have some potential to prevent the attachment of bacteria due to the presence of 
F− ions. Moreover, FAP is more stable than natural enamel in acidic conditions as demineralisation of fluorapatite 
begins at pH lower than 4.7, in contrast with the hydroxyapatite in enamel, which is more acid soluble (below 
pH = 5.5) due to the substitution of carbonate ions in the mineral crystal lattice2. The antibacterial properties 
of the synthesized materials in powder form, were evaluated after experiments with four common bacteria i.e. 
Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Bacillus cereus. To test the regenerative potential, the 
mineral powders were used as fillers in chitosan scaffolds. Chitosan is a natural polymer and has been widely 
used as the main scaffolding material both for bone regeneration19, and for restorative dental related applications 
like the restoration of periodontal tissues20. During our experiments, dental pulp stem cells (DPSCs) have been 
cultured on the mineral containing scaffolds for one month. Different tests have been conducted to investigate the 
biocompatibility of the materials and the potential of DPSCs to differentiate into osteoblasts.
Materials and Methods
Synthesis of fluorapatites and chitosan scaffolds. The synthesis of the fluorapatite minerals followed 
the precipitation method described in21 and22. In particular, 200 ml of 0.1 M Ca(NO3)2∙4H2O aqueous solution, 
was prepared (solution A) and then heated to 50 °C. After stabilizing the temperature, 200 ml of a 1 M (NH4)3PO4 
solution (solution B) containing the appropriate mass of NH4F, based on the stoichiometry of fluorapatite, was 
introduced dropwise to solution A. To maintain pH above 9, 0.1 M molar strength solution of NaOH was added 
dropwise during the mixing of A and B. The final mixture was left for 2 hours by continuous stirring at 50 °C for 
2 h and then left to settle for 1 h to allow precipitation of fluorapatite. During precipitation, the top of the beaker 
was sealed with aluminum foil for minimising ingress of CO2 into the phosphate mineral solution. The formed 
fluorapatite crystals, were collected on a filter paper (Whatman grade 44 with pores of 3 μm), washed several 
times with distilled water and then dried for 24 h at 80 °C. After filtration the powder was heat treated to 400 °C 
for 3 h. For the synthesis of the Sr2+ and the Ce3+ doped FAP, 5% mol of Sr(NO3)2 and 5%mol of Ce(NO3)3·6H2O 
respectively, were added into solution A before the dropwise addition of the (NH4)3PO4. Stirring, filtration and 
drying followed as it is described for the synthesis of the un-doped material. All the minerals used in the present 
study are presented in Tables 1 and 2.
For the fabrication of the chitosan-fluorapatite scaffolds, the fluorapatite powder (20% wt in respect with chi-
tosan) was dispersed in 2% v/v aqueous acetic acid solution. The mixture was processed in a sonicating bath for 
Code name Sr % mol. Ce % mol. Chemical formula
FAP — — Ca10(PO4)6F2
FAP-Sr 5 — Ca9.5Sr0.5(PO4)6F2
FAP-Ce — 5 Ca4.75Ce0.25(PO4)3F1.5O0.5
Table 1. Synthesized materials and expected chemical formulas.
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10 min for homogenous dispersion of the particles. High molecular chitosan powder was added into the solution 
(3%wt/v) and left to dissolve under continuous stirring at 50 °C. The chitosan/mineral mixture was injected into 
the 1 cm diameter cell cultivation wells and placed in a freezer overnight (−20 °C). The frozen samples were trans-
ferred into a freeze-dryer where they were held for 24 h until each sample was dry. To remove any traces of the 
solvent, the scaffolds were immersed in 1 M NaOH solution for 5 min and then washed with a phosphate buffer 
at pH 7.4. Treating chitosan scaffolds with NaOH, deprotonates and forms new hydrogen bonds, which helps in 
stabilising the chitosan scaffolds in aqueous environment by lowering their dissolution rate.
Characterisation techniques. A Bruker D8 powder diffraction spectrometer, with monochromatic Cu 
Kα radiation (0.1541 nm) was used for ascertaining the crystalline nature of the synthesized fluorapatite mineral 
powder. The diffractometer step size was 0.065° and the 2θ scanning range was from 10° to 60°, such that data 
were collected over a period of approximately 25 min with a scan speed of 0.014° s−1.
Scanning electron microscopy (SEM, a Hitachi SU8230 1–30 kV cold field emission gun) was used to inves-
tigate the size and shape of the synthesized crystals and also for characterising the porosity in chitosan scaffolds. 
The microscope was equipped with an Oxford Instruments 80 mm2 SD detector for energy dispersive X-ray (EDX) 
spectrometry with Aztec processing software to enable compositional analysis both of the mineral powders and the 
scaffolds. Since the calcium phosphate minerals have poor electrical conductivity, prior to SEM and EDX analysis, 
it was necessary to coat each sample with a 5 nm thick layer of iridium and then vacuum clean them for 10 min.
The FTIR spectra of the fluorapatite minerals and the chitosan scaffolds were acquired using an ATR-FTIR 
spectrometer (Bruker Vertex 70) for a range of wave numbers between 400 and 3000 cm−1.
Antibacterial properties and cell cultivation experiments. The antibacterial activity of the mineral 
powders was evaluated according to Varna, et al.23. Bacterial strains of E. coli (BL21) were used as the model 
Gram-negative bacteria and strains of S. aureus (ATCC 25923), B. cereus and B. subtilis were used as Gram-positive 
bacteria. The microorganisms left to grow in 100 ml of sterile nutrient broth (Luria-Bertani broth, LB) at 150 rpm 
and 37 °C. They were collected at the logarithmic stage of growth and formed suspensions with the addition of 
25 mM phosphate buffered saline (PBS, Sigma). The concentration of each suspension was adjusted to OD600 
(optical density at 600 nm) value of 0.5 before incubation with the respective powder sample. Each mineral was 
tested for three different concentrations namely 25, 50 and 100 μg/ml. After 24 h the absorbance was measured at 
OD600 in triplicates and in each case, we obtained the mean value for the reported data (average values ± SD). 
The IC50 values for each material-microorganism pair have been calculated based on the linear regression model.
Dental pulp stem cells (DPSC) isolation and culture. All the cell experiments were performed in 
accordance with relevant guidelines and regulations. Aiming to the isolation of DPSCs, upon extraction, the 
human deciduous tooth was received in 0.12% chlorexidin contained in Hank’s balanced solution and double 
washed with 2% penicillin-streptomycin (Pen/Strep) (Biowest) solution. By restraining the tooth with the help of 
a pincher and the use of multi-dimensional neuroextractors, the dental pulp was removed and placed in a solu-
tion of 4 mg/ml collagenase and 2 mg/ml dispase (SIGMA) dissolved in PBS and subsequently stirred for 45 min-
utes in a moving incubator in 37 °C. A complete α-MEM media supplemented with 100 mg/ml Pen/Strep, 2 mM 
L-glutamine, 0.1 mM L-ascorbic acid and 15% Fetal Calf Serum was added in a final volume of 10 ml resulting in 
centrifugation at 700 rcf, for 10 minutes in 20 °C. The pellet was resuspended in 2 ml of the same media and was 
finally plated in one well of a 6-well plate starting the cell culture in an incubator in 37 °C with 5% CO2 supply and 
media changes every 2–3 days upon confluence.
Preparation of scaffolds and cell plating. The fabricated scaffolds were sterilized in gradually reduced 
ethanol concentration solutions and after washing three times with distilled H2O were left to dry for approxi-
mately 4 hours under sterile conditions.
Fibrin glue was prepared following the blood sampling of a healthy volunteer donor as described previously 
in24 and used for covering the bottom of 48 well plates (15 μl per well). The materials were placed in the wells 
using a sterile pincher by applying minimal manual pressure and left to dry until complete adherence upon the 
plastic surfaces. DPSCs were detached via 0.05% Trypsin-EDTA (Biowest) and counted with Trypan Blue in a 
Neubauer cell counting chamber. 3 ∙ 105 cells were resuspended in α-MEM media supplemented with 10% FBS, 
penicillin (100 IU/ml) and streptomycin (100 lg/ml) and were subsequently injected per scaffold using an insulin 
syringe with an 18 G needle. Upon a 2-hour incubation, 500 μl α-MEM full medium were added per well for the 
initiation of culture upon the scaffolds.
Cell viability assays (MTT assay and preparation for SEM). Aiming the evaluation of the scaffold 
cytotoxicity, an MTT assay was performed (Sigma-Aldrich) 48 h after the initial plating of the DPSCs on the 
Code name Chitosan to acetic acid ratio
Filler mineral (ratio 
based on the chitosan)
CH
3% w/v (same concentration  
for all scaffolds)
No fillers
CHFAP 20% w/w FAP
CHFAP-Sr 20% w/w FAP-Sr
CHFAP-Ce 20% w/w FAP-Ce
Table 2. Fabricated chitosan scaffolds.
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scaffolds. As a control group, non-plated DPSCs, were used in the same number as the rest of the groups. Briefly, 
after removing the media from the wells, MTT reactant was added in 1:10 ratio with DMEM media followed by a 
4 h incubation in 37 °C and 5% CO2. The MTT was removed and 1 ml/well of DMSO was introduced for another 
one hour of incubation in the same conditions. The reduction of MTT to formazan was estimated at 570 and 
630 nm wavelength.
The observation of DPSCs morphology and differentiation capacity after 6 days upon co-culture on the scaf-
folds was performed after their fixation with 4% Paraformaldehyde for 20 min in RT and overnight air dry.
Quantification of secreted osteocalcin. The levels of the secreted osteocalcin in the culture supernatants 
was performed using a Human Osteocalcin Elisa kit (SIGMA) 15 days after the initial plating and according to the 
manufacturer’s instructions. The quantification was materialized in a Perkin Elmer VICTOR™ Multilabel Plate 
Reader and expressed in pg/ml. As a control group, the supernatant of a simple DPSCs culture, non-plated upon 
scaffolds, was used.
Real time PCR (RUNX2 expression). In order to compare the expression levels of genes correlated with 
differentiation to osteoblasts (RUNX2) in multi-treated scaffolds, real-time PCR was performed using a KAPA 
SYBR® FAST one step qPCR Master Mix (2X) Kit. In detail, 15 days after the DPSCs culture upon scaffolds, the 
latter ones were washed in PBS solution and the incorporated cells were detached using 0.05% Trypsin-EDTA 
(Biowest) and subsequent washes. RNA extraction and RNA quantification in a NanoDrop ND-1000 UV-Vis 
Spectrophotometer was carried out according to the manufacturer’s instructions. Upon the cautious primer 
designing (Table 3) and HPLC purification, for 10 ng of RNA template, Q-PCR was performed, the results of 
which were analysed using a ddCt algorithm in order to calculate the relative changes in gene expression.
ethical statement. This study was approved by the Ethics Committee of Aristotle University of Thessaloniki 
School of Medicine (390-9/1.7.2017). This research involves Human Participants after their informed consent. 
Human deciduous teeth for mesenchymal stem cells isolation were collected from healthy volunteer donors dur-
ing stem cell banking in Biohellenika SA Biotechnology Company. All the experiments regarding the cell work 
were performed in accordance with relevant guidelines and regulations.
Results
In Fig. 1 the X-ray powder diffraction data for the synthesised mineral powders are compared with the reference 
pattern of hexagonal fluorapatite (Ref. 04-009-4021). It is obvious that all the major peaks (for 2θ = 10.46, 25.95, 
32.04, 33.02, 34.07, 39.98, 47.06, 49.67 and 53.26) match completely with the reference and consequently, these 
three materials are confirmed to be fluorapatite minerals. The incorporation of Sr2+ and Ce3+ into the fluorapatite 
lattice does not seem to affect the crystallographic identity of the materials since both the un-doped material 
(FAP) and the doped ones (FAP-Sr and FAP-Ce) found to have very similar (but not identical) XRD patterns 
(same position and relatively intensity of the peaks). The most significant difference is the peak that appears at 
2θ = 50.5 for the FAP-Sr. Although this is not present neither to FAP or FAP-Ce it still can be found to the refer-
ence pattern of fluorapatite (Fig. 1). For the FAP-Sr was also observed a shifting of the peaks to lower angles by 
Gene Forward Primer Reverse primer
β-actin atctggcaccacaccttctacaatgagctgcg cgtcatactcctgcttgctgatccacatctgc
RUNX2 ttacttacaccccgccagt c tatggagtgctgctggtctg
Table 3. Primers designing for qPCR.
Figure 1. X-ray diffraction patterns of the fluorapatite minerals and comparison with a reference pattern for 
fluorapatite.
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0.2 degrees. The lack of significant alterations in the lattice dimensions of fluorapatite may be explained by con-
sidering the ionic radius of Sr2+ (132 pm) and Ce3+ (114 pm), which are comparable with that of Ca2+ (114 pm), 
suggesting that the effect of cationic substitution on lattice parameter is insignificant.
The FTIR spectra of the mineral powders and chitosan scaffolds are compared in Fig. 2a,b, respectively. All 
the fluorapatites present similar peaks attributed to the PO43− ion bands. Specifically, the v2 band was identified 
at 468 cm−1, v4 at 559 and 600 cm−1, and the v1 band at 962 cm−1. The higheste peak was found at 1026 cm−1 
and is assigned to the v3PO4 ion band (Fig. 2a). For the chitosan scaffolds, we observed peaks at 2918 cm−1 and 
2854 cm−1 due to the C-H stretch, 1637 cm−1 for the C=O streching, 1535 cm−1 (N-H stretch), a broad peak 
between 1409 and 1369 cm−1 due to C-H bending and a double peak at 1031 and 1074 cm−1 due to C-O-C 
bridge25. The presence of minerals in CHFAP, CHFAP-Sr and CHFAP-Ce is verified with the peaks at 559 cm−1, 
600 cm−1 and 962 cm−1 which are assigned to the PO43− ion bands as discussed before (Fig. 2b). The incorpora-
tion of mineral phase in chitosan changes the shape of peaks in the 800 to 1200 cm−1 range, suggesting that there 
might be molecular level interaction between the C-O-C and PO43− groups.
The shape morphologies of fluorapatite crystals are presented in Fig. 3a–c where its verified that there aren’t 
any differences between the un-doped and the doped materials since all three minerals apear to constitute from 
rod like crystals, which are about 60 nm long (Fig. 3a,c). During STEM, in all samples only the fluorapatite crys-
tals were identified which means that doping with Sr2+ and Ce3+ is not causing the formation of any secondary 
phases (e.g. metal nanoparticles) and consequently, it is assumed that these ions are incoprorated into the fluo-
rapatite lattice.
In Fig. 4 typical SEM images of a mineral containing scaffold are presented, which show an extended network 
of pores with size range between 100 and 250 μm in diameter. These pores have been evolved after freeze drying 
of the chitosan solution (Fig. 4a). Although the role of porosity in bone regeneration is well known, the optimal 
pore size is not yet defined and as a general rule of thumb, porosity within a range between 50 and 400 μm is 
reccomended26 and thus the pore size and distribution shown in Fig. 4a is consistent with the requirements for 
cell growth. As it is depicted in Fig. 4b,c, aggregates of crystalline minerals with an average diameter <1 μm are 
homogenously distributed in a chitosan matrix, which can also be verified by EDX mapping (e.g. Ce in Fig. 4d).
For understanding the antibacterial activity of each mineral, it is essential to know the corresponding disso-
lution rate in physiological conditions (pH = 7.4 and temperature of 37 °C). In Fig. 5, the weight % mass loss of 
each mineral (in powder form) in phosphate buffer (pH = 7.4) after 48 h is presented. In general, the resorption 
rate for all the materials is quite low which may be beneficial for bone regeneration since, the healing of the hard 
tissue often takes longer than 6 weeks. The higher mass loss was found for the undoped fluorapatite (2.5%) and 
it was followed by the Sr2+ doped material (1.4%). The lowest dissolution rate was observed for FAP-Ce (0.97%).
Figure 2. FTIR patterns of the fabricated materials; (a) patterns for the fluorapatite minerals (wavenumber 
range 300–1500 cm−1; (b) patterns of the chitosan scaffolds with and without minerals (wavenumber range 
400–4000 cm−1).
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After testing different concentrations of the powders with four different bacteria, we were able to identify the 
half maximal inhibitory concentration (IC50) of each material (Table 4). It was found that the undoped fluorap-
atite has the higher inhibition potential for all the bacteria tested since it presents the lowest IC50 values (around 
110 μg/ml for E. coli, 112 μg/ml for S. aureous and 119 μg/ml for B. subtilis and 156 μg/ml for B. cereus). Doping 
fluorapatite with Ce3+ has no particular effect on the antibacterial properties since, the IC50 values of FAP-Ce are 
very close to that of FAP, both for the Gram-negative (E. coli) and the Gram-positive (S. aureus, B. cereus and B. 
subtilis) bacteria. On the other hand, doping with Sr2+, seems to reduces the antibacterial potential of the mineral 
since there is a clear increase of the IC50 for all the bacteria tested. As it is presented in Table 4, the IC50 values for 
the FAP-Sr powder found to be between 30 and 60% higher than these of the undoped fluorapatite (FAP).
Measurements of metabolic activity (MTT) were carried out for all the chitosan scaffolds in order to deter-
mine the toxicity of our materials. Figure 6a shows statistically significant reduction in cell viability when com-
pared with the control only in the presence of the FAP-Ce. However, this reduction is not so high enough to deem 
the material toxic. In general, these results indicate good cytocompatibility of the synthesised minerals. This is 
also supported by the SEM images in Fig. 6b–e where the successful attachment of the cells was observed follow-
ing the completion of the cultures. The morphology of the cells on the scaffolds confirms the results of MTT for 
their non-cytotoxic effect of the tested materials on the biological functions of the DPSCs.
To determine the potential differentiation of the stem cells to osteoblasts, the concentration of osteocalcin after 
4 days was measured. As it is depicted in Fig. 7a, the lowest concentration was measured for the chitosan scaffolds 
with no containing minerals (11 μg/ml). For the fluorapatite (FAP) containing scaffolds, the concentration of oste-
ocalcin was considerably higher (22 μg/ml) but the maximum value was found for the scaffolds with the Ce doped 
mineral (31 μg/ml). These are in accordance with the findings from RUNX2 gene expression, where the highest 
values measured for Sr2+ and Ce3+ containing scaffolds (Fig. 7b). Based on these results is clear that adding Sr2+ 
or Ce3+ favours the differentiation of the pulp stem cells to osteoblasts, which indicates that the bone regenerative 
potential of the synthesized fluorapatite is enhanced (as a result of doping with these two types of ions).
Discussion
In this work we demonstrated the incorporation of Sr2+ and Ce3+ ions into the fluorapatite lattice, as a result of 
the cationic substitution of Ca2+ ions. The X-ray powder diffraction analysis and FTIR spectra imply that there are 
not major changes in the crystalline lattices of the doped minerals when compared with the undoped fluorapatite, 
and this is justified if we consider the similar ionic radii of Ca2+ with Sr2+ and Ce3+. However, this may change if 
the doping concentration is increased (in this work 5% mol). For example, in15 it was found that as the amount 
of Ce3+ increases, positions of Bragg peaks in hydroxyapatite changed and became broader, indicating that the 
resulting minerals were less crystalline than the undoped material.
Figure 3. SEM images of the synthesised fluorapatite minerals (powder form); (a) un-doped fluorapatite (FAP); 
(b) 5% Sr doped fluorapatite (FAP-Sr); (c) 5% Ce doped fluorapatite (FAP-Ce).
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Figure 4. Typical SEM images of the chitosan scaffolds (images from the CHFAP-Ce). (a) Porosity at the 
surface of the scaffold; (b) distribution of the mineral nanoparticles in the scaffold; (c) mineral nanoparticles at 
higher magnification; (d) typical EDX maps of Ca and Ce.
Figure 5. Mass loss of minerals after 48 h in a phosphate buffer (3 pellets of each mineral were tested, with 
initial mass of 0.25 g/pellet).
IC50 (μg/ml) E. coli S. aureus B. subtilis B. cereus
FAP 110 ± 7.5 112 ± 6.2 119 ± 7.3 156 ± 10.1
FAP-Sr 141 ± 6.0 149 ± 10.1 191 ± 11.2 239 ± 13.1
FAP-Ce 107 ± 7.1 135 ± 9.3 133 ± 8.1 165 ± 11.5
Table 4. Half maximal inhibitory concentration (IC50) value of FAP, FAP-Sr and FAP-Ce for E. coli, S. aureus, B. 
subtilis and B. cereus.
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The minerals synthesized herein were found to have significant antibacterial activity, and particularly the 
undoped and the Ce-doped fluorapatite (FAP and FAP-Ce) which present similar behaviour. In a systematic work 
of Wu et al.27, the IC50 of hydroxyapatite NPs for E. coli and S. aureus was found to be 29 mg/ml and >100 mg/ml 
respectively. For the fluorapatites presented in this work the IC50 values for the same bacteria are almost one order 
of magnitude lower (Table 4) making apparent the high antibacterial potential. Although there are numerous 
reports about the general antibacterial effect of fluoride, little work has been published regarding the antibacterial 
action of fluorapatite (fluoride incorporated in calcium phosphate). In a recent work of Alhilou et al.28, fluorap-
atite was investigated as a potential coating material for dental scaffolds/implants and it was demonstrated that 
it significantly reduces the viability of the adherent bacteria for all the bacterial strains tested (i.e. P. gingivalis, 
F. nucleatum, A. actinomycetemcomitans). These results are in agreement with the findings of the present 
Figure 6. Interaction of the fabricated scaffolds with DPSCs. (a) Measurements of metabolic activity (MTT 
assay); SEM micrographs of the DPSCs on (b) CH, (c) CHFAP, (d) CHFAP-Sr) and (e) CHFAP-Ce scaffolds. 
Cells migrate from the culture media and occupy the pores of the scaffold (scale bars of 70 μm).
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work where, we demonstrated that the FAP minerals have the potential to inhibit bacterial growth both for 
Gram-negative and Gram-positive bacterial strains (Table 4). Doping FAP lattice with Sr2+ resulted in the atten-
uation of the inhibition effect almost for all the cases tested (higher IC50 as is presented in Table 4). As already 
discussed in introduction, the antibacterial potential of Sr2+ is disputable since there are reports supporting both 
cases (e.g.12,14), and thus the exact mechanism of how Sr2+ ions affect different bacteria types remains unclear. One 
important factor for explaining the different behaviour of FAP and FAP-Sr is the lower degradation rate of the 
latter. Since the mass loss of the Sr2+-doped mineral is lower than that of FAP, less F ions (which are responsible 
for the antibacterial effect of fluorapatite) are released, allowing higher bacteria growth rates. Although doping 
with Ce3+ results even lower degradation rate, the antibacterial effect of the FAP-Ce mineral found to be almost 
the same with that of FAP. From the literature it is evident that doping with Ce3+, significantly improves the anti-
bacterial ability of the apatite minerals15,29. Consequently, we may assume that in the case of FAP-Ce, the observed 
inhibition is the result of the synergistic action of the F− and Ce3+ ions.
To check the regenerative potential, the mineral powders used as fillers in chitosan scaffolds and tested with 
human dental pulp stem cells (DPSCs). Based on the analysed concentrations of osteocalcin and the RUNX2 
expression, the scaffolds containing the FAP-Sr (29.4 μg/ml osteocalcin) and the FAP-Ce (31.0 μg/ml osteocal-
cin) induced considerably higher osteogenic differentiation of the pulp stem cells than the undoped fluorapatite 
(21.0 μg/ml osteocalcin) or the chitosan scaffolds without mineral fillers (11.1 μg/ml osteocalcin). The ability of 
Sr2+ ions to increase the bioactivity of apatite biomaterials and to promote the osteogenic gene expression is well 
documented in literature. In agreement with the results of other reports30, we demonstrated that the presence of 
Sr2+ in the scaffold enhances the osteogenic proliferation of human dental pulp stem cells (DPSCs), and thus it 
can be an effective option for the regeneration of dental tissues (e.g. coating of dental implants). The addition of 
cerium Ce3+ found to have a similar effect. In general, due to the similar ionic radii with Ca2+, cerium can present 
diverse biological effects31 and it is well known for its pharmaceutical applications (e.g. antiemetic and antiseptic). 
However, as it is concluded from our results it can also promote the osteogenic differentiation of DPSCs when 
is incorporated into fluorapatite lattice. Although there are not many reports about the interaction of Ce with 
DPSCs, Ce3+ found to enhance the osteogenic proliferation of bone mesenchymal stem cells BMSCs when was 
added to hydroxyapatite coatings32.
Conclusions
In this work we investigated the incorporation of Sr2+ and Ce3+ ions into fluorapatite powders aiming to a mate-
rial with enhanced antibacterial properties and regenerative potential. The most important findings of this work 
can be summarised in the following:
•	 In terms of materials synthesis, we demonstrated that fluorapatite can be doped with low concentrations of 
Sr2+ and Ce3+ without affecting its crystal structure.
•	 The undoped fluorapatite found to have better antibacterial response both for Gram- positive and Gram-neg-
ative bacteria. The antibacterial activity is reduced with the addition of Sr2+ but it remains almost the same 
when doping with Ce3+.
•	 The osteogenic potential of the Ce3+ doped mineral found to be the same with that of the Sr2+ doped mineral. 
In particular, after experiments with DPSCs the same concentration of osteocalcin was measured for both 
materials, indicating similar degree of osteogenic differentiation.
Based on previous works in literature we expected the good antibacterial properties of fluorapatite and the 
exceptional osteogenic potential of Sr2+ doped minerals. In this work for the first time we demonstrated that the 
incorporation of Ce3+ into fluorapatite lattice, results a material which combines both of the aforementioned prop-
erties and results into an improved biomaterial. Although more systematic work is needed (e.g. optimising the dop-
ing concentration), cerium doped fluorapatite seems to be a promising biomaterial that could provide solutions for 
significant clinical conditions where bacterial contamination is a critical problem as for example peri-implantitis.
Figure 7. Differentiation of the DPSCs to osteoblasts. (a) Concentration of osteocalcin on each scaffold.  
(b) Expression of RUNX2 gene.
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